Fisher & Paykel Healthcare Corporation Stock Forecast for 2023 - 2025 - 2030
Updated on 04/19/2024
Fisher & Paykel Healthcare Corporation Stock Forecast and Price Target
The average price target for Fisher & Paykel Healthcare Corporation's stock of $23.50 recently provided by four leading analysts would represent a -11.45% downside from its last closing price if reached. This potential increase is based on a high estimate of $29.10 and a low estimate of $18.40. If you're not interested in FPH stock, you may be interested in its competitors.
-11.45% Downside
Fisher & Paykel Healthcare Corporation Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Fisher & Paykel Healthcare Corporation's Price has seen a drop from $22.04 to $0.00 – a 100.00% decrease. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach $25.13 – an increase of 100.00%. Over the next six years, experts anticipate that Fair Value growth for Fisher & Paykel Healthcare Corporation will be 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A005930 Stock Forecast | Samsung Electronics | Outperform |
10
|
₩79.60k | Buy/Sell | ₩92.49k | 25.63% |
| RMD Stock Forecast | ResMed Inc | Outperform |
17
|
$177.61 | Buy/Sell | $201.32 | 15.42% |
| A066570 Stock Forecast | LG Electronics | Outperform |
18
|
₩92.60k | Buy/Sell | ₩139.81k | 40.39% |
| 4106 Stock Forecast | Wellell | - |
17
|
NT$28.90 | Buy/Sell | NT$0.00 | -100.00% |
| 1612 Stock Forecast | Vincent Medical Holdings | Buy |
18
|
HK$0.39 | Buy/Sell | HK$0.95 | 69.23% |
Fisher & Paykel Healthcare Corporation Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Revenue for Fisher & Paykel Healthcare Corporation has grown by 25.12%, going from $1.26B to $1.58B. In the coming year, analysts are expecting an increase in Revenue, predicting it will reach $1.93B – an increase of 21.99%. Over the next six years, experts anticipate that Revenue growth for Fisher & Paykel Healthcare Corporation will be 46.26%.
.jpg)
Fisher & Paykel Healthcare Corporation Dividend per Share Forecast for 2023 - 2025 - 2030
Fisher & Paykel Healthcare Corporation's Dividend per Share has grown in the last three years, jumping from $0.28 to $0.41 – an increase of 46.43%. In the next year, analysts predict that Dividend per Share will reach $0.42 – an increase of 2.44%. For the next six years, the forecast is for Dividend per Share to grow by 30.63%.
Fisher & Paykel Healthcare Corporation EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Fisher & Paykel Healthcare Corporation's EBITDA has decreased from $425.60M to $409.50M – a 3.78% drop. For next year, the 16 analysts predict EBITDA of $575.89M, which would mean an increase of 40.63%. Over the next six years, the pros' prediction is EBITDAof $1.18B, which would mean a six-year growth forecast of 189.13%.
Fisher & Paykel Healthcare Corporation EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Fisher & Paykel Healthcare Corporation's EBIT has decreased by 12.42%, going from $379.30M to $332.20M. In the next year, analysts expect EBIT to reach $449.17M – an increase of 35.21%. For the next six years, the forecast is for EBIT to grow by 86.95%.
Fisher & Paykel Healthcare Corporation EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Fisher & Paykel Healthcare Corporation's EPS has seen a drop from $0.50 to $0.00 – a 100.00% decrease. In the coming year, analysts are expecting an increase in EPS, predicting it will reach $0.57 – an increase of 100.00%. Over the next six years, experts anticipate that EPS growth for Fisher & Paykel Healthcare Corporation will be 100.00%.
Site Navigation
.jpg)